Home/Filings/4/0000899243-17-010583
4//SEC Filing

HELIUS MEDICAL TECHNOLOGIES, INC. 4

Accession 0000899243-17-010583

$HSDTCIK 0001610853operating

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 6:57 PM ET

Size

8.6 KB

Accession

0000899243-17-010583

Insider Transaction Report

Form 4
Period: 2017-04-17
Sackier Jonathan
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-04-17+473,376473,376 total
    Exercise: $1.63Exp: 2027-04-17Class A Common Stock (473,376 underlying)
  • Award

    Stock Option (Right to Buy)

    2017-04-17+326,624326,624 total
    Exercise: $1.63Exp: 2027-04-17Class A Common Stock (326,624 underlying)
Footnotes (3)
  • [F1]Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16
  • [F2]Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F3]Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.

Issuer

HELIUS MEDICAL TECHNOLOGIES, INC.

CIK 0001610853

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001610853

Filing Metadata

Form type
4
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 6:57 PM ET
Size
8.6 KB